Emergence of Carbapenem-resistant ST131 Carrying in Germany, 2019 to 2020

Overview

Journal Euro Surveill

Specialty Infectious Diseases

Date 2020 Nov 20

PMID 33213685

Citations 9

Authors

Sybille Welker

Sebastien Boutin

Thomas Miethke

Klaus Heeg

Dennis Nurjadi

Affiliations

Soon will be listed here.

Abstract

The dissemination of carbapenem-producing Gram-negative bacteria is a major public health concern. We report the first detection of OXA-244-producing ST131 O16:H5 in three patients from two tertiary hospitals in the south-west of Germany. OXA-244 is emerging in Europe. Because of detection challenges, OXA-244-producing may be under-reported. The emergence of carbapenem resistance in a globally circulating high-risk clone, such as ST131 is of clinical relevance and should be monitored closely.

Citing Articles

Emergence of ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024.

Kohlenberg A, Svartstrom O, Apfalter P, Hartl R, Bogaerts P, Huang T Euro Surveill. 2024; 29(47).

PMID: 39574387 PMC: 11583312. DOI: 10.2807/1560-7917.ES.2024.29.47.2400727.

Antimicrobial consumption and resistance in bacteria from humans and food-producing animals: Fourth joint inter-agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from....

EFSA J. 2024; 22(2):e8589.

PMID: 38405113 PMC: 10885775. DOI: 10.2903/j.efsa.2024.8589.

Clinical isolates of ST131 OXA-244-positive , Italy, December 2022 to July 2023.

Piazza A, Corbella M, Mattioni Marchetti V, Merla C, Mileto I, Kuka A Euro Surveill. 2024; 29(8).

PMID: 38390649 PMC: 10899817. DOI: 10.2807/1560-7917.ES.2024.29.8.2400073.

Regional spread of an atypical ESBL-producing ST131H89 clone among different human and environmental reservoirs in Western Switzerland.

Martischang R, Seth-Smith H, Verschuuren T, Hequet D, Gaia N, Francois P Antimicrob Agents Chemother. 2024; 68(2):e0092523.

PMID: 38169291 PMC: 10848748. DOI: 10.1128/aac.00925-23.

ESKAPE and Beyond: The Burden of Coinfections in the COVID-19 Pandemic.

Loyola-Cruz M, Gonzalez-Avila L, Martinez-Trejo A, Saldana-Padilla A, Hernandez-Cortez C, Bello-Lopez J Pathogens. 2023; 12(5).

PMID: 37242413 PMC: 10222376. DOI: 10.3390/pathogens12050743.

References

Nicolas-Chanoine M, Bertrand X, Madec J . Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014; 27(3):543-74. PMC: 4135899. DOI: 10.1128/CMR.00125-13. View

Potron A, Poirel L, Dortet L, Nordmann P . Characterisation of OXA-244, a chromosomally-encoded OXA-48-like β-lactamase from Escherichia coli. Int J Antimicrob Agents. 2015; 47(1):102-3. DOI: 10.1016/j.ijantimicag.2015.10.015. View

Page A, Cummins C, Hunt M, Wong V, Reuter S, Holden M . Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015; 31(22):3691-3. PMC: 4817141. DOI: 10.1093/bioinformatics/btv421. View

Falgenhauer L, Nordmann P, Imirzalioglu C, Yao Y, Falgenhauer J, Hauri A . Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland. Int J Antimicrob Agents. 2020; 56(6):106157. DOI: 10.1016/j.ijantimicag.2020.106157. View

Matuschek E, Ahman J, Webster C, Kahlmeter G . Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect. 2017; 24(8):865-870. DOI: 10.1016/j.cmi.2017.11.020. View

Peirano G, Bradford P, Kazmierczak K, Badal R, Hackel M, Hoban D . Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis. 2014; 20(11):1928-31. PMC: 4214325. DOI: 10.3201/eid2011.141388. View

Bankevich A, Nurk S, Antipov D, Gurevich A, Dvorkin M, Kulikov A . SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012; 19(5):455-77. PMC: 3342519. DOI: 10.1089/cmb.2012.0021. View

Pitout J . Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev Anti Infect Ther. 2012; 10(10):1165-76. DOI: 10.1586/eri.12.110. View

Hoyos-Mallecot Y, Naas T, Bonnin R, Patino R, Glaser P, Fortineau N . OXA-244-Producing Escherichia coli Isolates, a Challenge for Clinical Microbiology Laboratories. Antimicrob Agents Chemother. 2017; 61(9). PMC: 5571363. DOI: 10.1128/AAC.00818-17. View

10.

Emeraud C, Biez L, Girlich D, Jousset A, Naas T, Bonnin R . Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant?. J Antimicrob Chemother. 2020; 75(8):2120-2123. DOI: 10.1093/jac/dkaa155. View

11.

Feldgarden M, Brover V, Haft D, Prasad A, Slotta D, Tolstoy I . Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates. Antimicrob Agents Chemother. 2019; 63(11). PMC: 6811410. DOI: 10.1128/AAC.00483-19. View

12.

Oteo J, Hernandez J, Espasa M, Fleites A, Saez D, Bautista V . Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. J Antimicrob Chemother. 2012; 68(2):317-21. DOI: 10.1093/jac/dks383. View

13.

Masseron A, Poirel L, Falgenhauer L, Imirzalioglu C, Kessler J, Chakraborty T . Ongoing dissemination of OXA-244 carbapenemase-producing Escherichia coli in Switzerland and their detection. Diagn Microbiol Infect Dis. 2020; 97(3):115059. DOI: 10.1016/j.diagmicrobio.2020.115059. View

14.

Jia B, Raphenya A, Alcock B, Waglechner N, Guo P, Tsang K . CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 2016; 45(D1):D566-D573. PMC: 5210516. DOI: 10.1093/nar/gkw1004. View

15.

Gupta S, Padmanabhan B, Diene S, Lopez-Rojas R, Kempf M, Landraud L . ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother. 2013; 58(1):212-20. PMC: 3910750. DOI: 10.1128/AAC.01310-13. View

16.

Fursova N, Astashkin E, Knyazeva A, Kartsev N, Leonova E, Ershova O . The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia. Ann Clin Microbiol Antimicrob. 2015; 14:46. PMC: 4630924. DOI: 10.1186/s12941-015-0108-y. View

17.

Dahbi G, Mora A, Mamani R, Lopez C, Alonso M, Marzoa J . Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131. Int J Med Microbiol. 2014; 304(8):1247-57. DOI: 10.1016/j.ijmm.2014.10.002. View

18.

Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O . Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012; 67(11):2640-4. PMC: 3468078. DOI: 10.1093/jac/dks261. View

19.

Poirel L, Potron A, Nordmann P . OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012; 67(7):1597-606. DOI: 10.1093/jac/dks121. View

20.

Albiger B, Glasner C, Struelens M, Grundmann H, Monnet D . Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015; 20(45). DOI: 10.2807/1560-7917.ES.2015.20.45.30062. View